Yahoo Finance

Apricus mulls options; to sell U.S. rights to Vitaros

* Co has lost $65 mln in market cap since Feb rejection of Vitaros (Adds details on options, background, shares) April 16 (Reuters) - Apricus Biosciences Inc said on Monday it was considering options ...
NBC News

Apricus Biosciences Expands Patent Coverage in Mexico for Its Erectile Dysfunction Drug, Vitaros(R)

SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that the Mexican Patent Office ("MPO") will grant an additional patent for ...
Yahoo Finance

Apricus Biosciences Announces Outcome of Vitaros(TM) End-of-Review Meeting with FDA

SAN DIEGO, April 16, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced the outcome of ...
NBC News

Apricus Biosciences and Neopharm Group Sign Licensing Agreement for Vitaros(R) in Israel for up to $4.35 Million, Plus Royalties

SAN DIEGO, Feb. 14, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI), announced today that it has entered into a licensing agreement granting Neopharm Group ("Neopharm" ...
Reuters

Apricus mulls options; to sell U.S. rights to Vitaros

(Reuters) - Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug ...